1. Diabetes Care Program of Nova Scotia. Department of Health and Wellness SEAscape Database, June 2011.
  2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Erratum in Lancet 1999 Aug 14;354(9178):602. Lancet. 1998 Sep 12;352(9131):837-53.
  3. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560-72. Epub 2008 Jun 6.
  4. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD. Glucose control and vascular complications in veterans with type 2 diabetes. VDAT Study. N Engl J Med. 2009 Jan 8;360(2):129-39. Epub 2008 Dec 17. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1028. N Engl J Med. 2009 Sep 3;361(10):1024-5.
  5. Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59. Epub 2008 Jun 6.
  6. Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, et al. Intensive glycemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomized clinical trials. BMJ. 2011 Nov 24;343:d6898. doi: 10.1136/bmj.d6898. Review.
  7. Coca SG, Ismail-Bergi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med. 2012 May 28;172(10):761-9. Review. Erratum in: Arch Intern Med. 2012 Jul 23;172(14):1095.
  8. Review. Erratum in: Arch Intern Med. 2012 Jul 23;172(14):1095
  9. Mallery LH, Ransom T, Steeves B, Cook B, Dunbar P, Moorhouse P. Evidence-informed guidelines for treating frail older adults with type 2 diabetes From the Diabetes Care Program of Nova Scotia (DCPNS) and Palliative and Therapeutic Harmonization (PATH) Program. J Am Med Dir Assoc. 2013 Sept 24. doi:pii: S1525-8610(13)00460-X. 10.1016/j.jamda.2013.08.002. [Epub ahead of print]